Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction

被引:23
作者
Chonchol, Michel
Goldenberg, Ilan
Moss, Arthur J.
McNitt, Scott
Cheung, Alfred K.
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Denver, CO 80262 USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[3] Univ Utah, Salt Lake City, UT USA
[4] Vet Affairs Salt Lake City Heathcare Syst, Salt Lake City, UT USA
关键词
renal insufficiency; chronic; beta-blockers; left ventricular dysfunction; cardiac death; sudden;
D O I
10.1159/000098431
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with ischemic left ventricular dysfunction have a high risk of sudden cardiac death (SCD). It is, however, unclear if the risk and risk factors of SCD in these patients is modulated by the coexistence of mild chronic renal insufficiency. Methods: We performed a post-hoc analysis of the outcome associated with mild renal dysfunction, as defined by an estimated glomerular filtration rate (eGFR) of < 75 ml/min/1.73 m(2) in patients allocated to the conventional medical therapy arm of the Multicenter Automatic Defibrillator Implantation Trial-II. Results: In multivariable analysis, renal dysfunction was independently associated with significant increased risks for all-cause mortality (hazard ratio [HR] = 1.86; 95% CI 1.13-3.05) and SCD (HR = 2.00; 95% CI 1.01-4.02), but not non-SCD, compared to patients without renal dysfunction. Independent predictors of SCD in patients with renal dysfunction were: increased resting heart rate (HR = 2.40; 95% CI 1.50-3.86); low diastolic blood pressure (HR = 3.23; 95% CI 1.52-6.66), and a prolonged QRS duration (HR = 1.63; 95% CI 1.02-2.61). beta-Blocker therapy was independently associated with a significant reduction in the risk of SCD in patients with an eGFR of < 75 ml/min/1.73 m(2) (HR = 0.61; 95% CI 0.38-0.99). Conclusion: These findings suggest that renal dysfunction significantly increases the risk for SCD in patients with left ventricular dysfunction, and that beta-blocker therapy reduces the risk of arrhythmic mortality in heart failure patients with coexisting renal insufficiency. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 35 条
[31]   Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction [J].
Smilde, Tom D. J. ;
van Veldhuisen, Dirk J. ;
Navis, Gerjan ;
Voors, Adriaan A. ;
Hillege, Hans L. .
CIRCULATION, 2006, 114 (15) :1572-1580
[32]   Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency [J].
Tonelli, M ;
Moyé, L ;
Sacks, FM ;
Kiberd, B ;
Curhan, G .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (02) :98-104
[33]   Heart failure as a cause for hospitalization in chronic dialysis patients [J].
Trespalacios, FC ;
Taylor, AJ ;
Agodoa, LY ;
Bakris, GL ;
Abbott, KC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (06) :1267-1277
[34]   Leptin and renal disease [J].
Wolf, G ;
Chen, S ;
Han, DC ;
Ziyadeh, FN .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (01) :1-11
[35]   Acute myocardial infarction and renal dysfunction: A high-risk combination [J].
Wright, RS ;
Reeder, GS ;
Herzog, CA ;
Albright, RC ;
Williams, BA ;
Dvorak, DL ;
Miller, WL ;
Murphy, JG ;
Kopecky, SL ;
Jaffe, AS .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (07) :563-570